Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Ingevity (NGVT) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Ingevity (NGVT) over the last 11 years, with Q3 2025 value amounting to $199.2 million.

  • Ingevity's Cost of Revenue fell 148.37% to $199.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $976.8 million, marking a year-over-year decrease of 444.14%. This contributed to the annual value of $951.7 million for FY2024, which is 2200.46% down from last year.
  • Ingevity's Cost of Revenue amounted to $199.2 million in Q3 2025, which was down 148.37% from $227.2 million recorded in Q2 2025.
  • Ingevity's Cost of Revenue's 5-year high stood at $379.8 million during Q4 2024, with a 5-year trough of $170.6 million in Q1 2025.
  • Its 5-year average for Cost of Revenue is $257.0 million, with a median of $245.0 million in 2022.
  • In the last 5 years, Ingevity's Cost of Revenue surged by 3008.51% in 2022 and then tumbled by 3621.45% in 2024.
  • Ingevity's Cost of Revenue (Quarter) stood at $231.0 million in 2021, then rose by 20.43% to $278.2 million in 2022, then rose by 12.22% to $312.2 million in 2023, then rose by 21.65% to $379.8 million in 2024, then tumbled by 47.55% to $199.2 million in 2025.
  • Its Cost of Revenue stands at $199.2 million for Q3 2025, versus $227.2 million for Q2 2025 and $170.6 million for Q1 2025.